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with biodegradable tips. The microneedles array was fabricated by using deep reactive ion etching (DRIE)
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overcomes the difficulty in the undercut control of the tips during the classical isotropic silicon etching
process. When the silicon tips were formed, the porous tips were then generated using a classical
electrochemical anodization process in MeCN/HF/H2O solution. The paper presents the experimental
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TRANSDERMAL DRUG DELIVERY: MICROFABRICATION INSIGHTS
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Abstract–The paper presented an enhancement solution for
transdermal drug delivery using microneedles array with
biodegradable tips. The microneedles array was fabricated
by using deep reactive ion etching (DRIE) and the
biodegradable tips were made to be porous by
electrochemical etching process. The porous silicon
microneedle tips can greatly enhance the transdermal drug
delivery in a minimum invasion, painless, and convenient
manner, at the same time; they are breakable and
biodegradable. Basically, the main problem of the silicon
microneedles consists of broken microneedles tips during
the insertion. The solution proposed is to fabricate the
microneedle tip from a biodegradable material – porous
silicon. The silicon microneedles are fabricated using DRIE
notching effect of reflected charges on mask. The process
overcomes the difficulty in the undercut control of the tips
during the classical isotropic silicon etching process. When
the silicon tips were formed, the porous tips were then
generated using a classical electrochemical anodization
process in MeCN/HF/H2O solution. The paper presents the
experimental results of in vitro release of calcein and BSA
with animal skins using a microneedle array with
biodegradable tips. Compared to the transdermal drug
delivery without any enhancer, the microneedle array had
presented significant enhancement of drug release.
Keywords: Microneedles, biodegradable, transdermal
delivery.

1. INTRODUCTION
Transdermal delivery is an attractive method to
deliver drugs or biological compounds into
human body, for its distinct advantage of
eliminating pain and inconvenient intravenous
injections. However, the efficiency of
transdermal delivery is greatly limited by the
poor permeability of the hard layer of skin at the
stratum corneum (SC) which is the outmost layer
of skin that forms the primary transport barrier
[1]. The rate of transdermal drug diffusion also
depends in part on the size and hydrophilicity of
the drug molecules, which usually takes a long
time, up to hours or days, and it may not be
convenient or practical for clinical application.
Due to this fact, only small doses (<10 mg/day)
of lipophilic and low-molecular weight drugs (<
500 Da) can be successfully delivered via
transdermal method [2]. A number of methods
have been developed in order to improve drug

transport across the skin, methods that include
mechanical [3] or chemical enhancers [4],
iontophoresis [5], electroporation [6] and
sonophoresis [7].
The solid microneedle array, first reported by
Henry et al in [8], was used as a mechanical
enhancer to improve the drug penetration through
the skin. In this technique, micro-sized needles
protrude through the primary biological barrier of
TDD, the stratum corneum, yet without affecting
the dermis layer that contains nerves and blood
vessels, thus avoiding pain and bleeding (shown
in Figure 1). Moreover, the microneedle arrays
have the advantage of a uniform delivery of the
drug. Because these devices are fabricated using
microfabrication technology, they can be easily
scaled up for cheap and reproducible mass
production. So far, a wide variety of microneedles
fabricated from different materials has been
reported. Arrays of hollow out-of-plane silicon
microneedles were presented in [9] by Stoeber
and Liepmann, while microneedles with
biodegradable tips (mesoporous silicon) were
reported in [10]. Other materials were explored as
well: polysilicon [11], and even polymers [12,
13]. Metal microneedles have also been targeted
for transdermal drug delivery mainly due to their
good mechanical properties and biocompatibility
[14, 15]. In vitro and in vivo (on diabetic mice)
studies demonstrate the delivery of insulin [16,
17]. Lin et al [18] used microneedles to deliver
20-mer phosphorothioated oligodeoxynucleotides
across the skin of hairless guinea pigs. In [19]
Matriano et al demonstrated the delivery of
ovalbumin as a model protein coated onto a
needle
surface.
Recently,
“dissolving
microneedles” were reported, i.e. microneedles
which encapsulate the drug to be delivered and
which slowly dissolve within the skin [20].
Basically, the microneedles are fabricated by
silicon with MEMS technologies. The various
shapes and profiles of silicon microneedles, either
hollow or solid needles, can be fabricated using
the DRIE process [21-23].
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Fig. 1. Microneedles can create pathways into the skin for
drug delivery and are painless due to their size

However, due to the high-aspect-ratio needle
structure and fragility of silicon, these
microneedles have some several shortcomings.
The main problem of the silicon microneedles is
that it breaks easily during the insertion process
into the skin (Figure 2), and this increases the
possibility of an infection. The solution proposed
here is to fabricate the microneedles tip from a
biodegradable porous silicon material. This
porous silicon is well-known as nano-structured
silicon and good for biological applications
because of its bioactive and biodegradable
properties [24-25]. The microneedles have been
fabricated to have macro porous tips by using
electrochemical etching process. These porous
tips may break off after the drug delivery process
and be allowed to remain in the skin, as it can be
easily biodegraded within 2 to 3 weeks.

Fig. 2. SEM image showing the tip of a broken microneedle
after insertion into a pig skin.

Here we report the development of silicon
microneedles array with biodegradable tips. The
silicon microneedles array was fabricated by
using notching effects of reactive ion etching

(RIE). The macroporous tips were fabricated
using a classical anodization process in
MeCN/HF/H2O solution. The microneedles array
was tested in vitro with an animal skin model by
using a comparative study (bare skin diffusion
and diffusion through the microneedle array).
Calcein (molecular weight of 623 Da) and bovine
serum albumin (BSA) - molecular weight of
66.430 kDa were investigated in the drug
delivery. The drug release profile was
characterized using UV spectra detection, and the
results showed that microneedles can enhance the
calcein release rate by 5 times compared to
conventional transdermal drug delivery methods
without enhancers. Similarly, the enhancement
factors of microneedle array for BSA were 7
times compared to the bare diffusion rate.

2. DESIGN AND FABRICATION
The micro-sized needles are designed to
penetrate the primary biological barrier of stratum
corneum and the epidermis but without
penetrating into the dermis layer that contains
nerves and blood vessels, thus avoiding pain and
bleeding. In our application, we chose to fabricate
the microneedle arrays from silicon, making use
of microfabrication techniques, mainly due to
simplicity of the fabrication process. The
microneedles are out-of-plane, 100 μm high, and
arrayed in a 30 × 30 matrix on a 12 × 2 mm2
silicon chip. Since the stratum corneum of skin
has a depth of 10~20 μm, and epidermis has a
variable depth of 50~100 μm, the penetrating
length of the microneedles is preferred to be
around 100 μm.
Furthermore, in order to have an easy
penetration into the skin, the microneedles should
have a high aspect ratio. The fabrication of the
microneedles was realized using an optimized
SF6/O2 RIE process. By controlling the two gas
flow rate, the microneedles were fabricated with
an aspect ratio of 3:1 (height: width of the needle
base) [26]. The isotropic profile of the
microneedles was fabricated using two effects:
flowing of thick photoresist mask and notching
effect of the reflected charges on mask. It is a
well-known property of the thick photoresist that
it reflows when it is heated at 120 °C [27]. The
modification of the vertical wall of the patterned
photoresist can reflect the charges (ions and
radials) during the RIE process and in this way
generates the etched profile under the oxide
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mask. This phenomenon has also been reported
for the Bosch process [28].

Fig. 3. Notching effect of reflected charges on mask.

piranha solution (H2SO4: H2O2 = 2:1) at 120°C
for 20 minutes and then rinsed in DI water and
spun dried (Fig. 5a). On the silicon wafer a 0.5
μm-thick SiO2 was deposited at 300°C, from
SiH4 and N2O, at a pressure of 700 mTorr and a
power of 300 W using STS-PECVD equipment
(Fig. 5b). A photoresist mask using AZ9260
positive photoresist (from Clariant), with a
thickness of 8 μm, was used for the patterning of
the SiO2-PECVD layer (Fig. 5c). The pattern is
transferred to the SiO2 layer using a RIE etching
system with CHF3: He gases on RIE dielectrics
Adixen AMS100 (Figure 5d). After the patterning
of the oxide layer, the tips were generated using
an isotropic RIE process (Fig. 5e and 5f) with
SF6/O2 in an ICP DRIE system. The process was
optimized for a better control undercut, and with
a depth-to-width aspect ratio of 3:1 [26]. A SEM
image with the needles is presented in Fig. 6.

Fig. 4. SEM image with released microneedles.

Figure 3 is an example of the notching effect
of reflected charges on the mask where ions and
radicals with high energy are reflected by the
oblique profile of the photoresist and generate an
increased etching under the mask. The process
eliminates the difficulty in the undercut control
of the tips during the classical isotropic silicon
etching process. Also, the end of the process can
be very easily monitored using the video-camera
of the “End Point Detection System” of the deep
RIE tool. Once the required shape of the tip is
achieved, the square shape of the mask is
modified and we could observe the different
rectangular shapes that correspond to the
projection of the tiled square mask on the
monitor. An SEM image that illustrates the
released microneedles at the masking layer is
presented in Fig. 4.
The main steps of the fabrication process of the
microneedles are presented in Fig. 5. A 4” silicon
wafer with <100> crystallographic orientation, ntype 1~10 ohm-cm was initially cleaned in

Fig. 5. Fabrication process of nanotips: a) silicon wafer, b)
PECVD SiO2, c) photoresist mask d) etching of SiO2, e)
plasma etching in SF6, f) release of nanotips

Fig. 6. SEM picture of the fabricate microneedle.
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3. FABRICATION PROCESS OF THE
BIODEGRADABLE TIPS
After the fabrication of the silicon
microneedles array, the following target was to
develop an anodization process that allows the
conversion of a single crystal silicon material of
the tip into a porous structure. In order to achieve
this, the “body” of the microneedles must be
protected with a Si3N4 layer, releasing only the
tip to be exposed during the anodization process.
The main steps of the porous tips fabrication are
shown in Fig. 7.

reactor
[29, 30] (Figure 7a). With relatively
good results, also PECVD SiC [31, 32] was can
be used for the needles covering. A thick layer of
photoresist AZ9260 was spun twice on the
surface of the microneedles, followed by baking
at 120 °C for 15 min (Figure 7b). Due to the
flowing effect, the photoresist covering the tips of
the needles was much thinner than those at the
body and at the bottom. Thus the photoresist on
the tips of the microneedles was cleaned/removed
in an O2 plasma etching process in RIE System
(Fig. 7c). In this way only the top part of the
needle is free of photoresist and the Si3N4 layer
on the microneedle tips can be removed using a
RIE process (CHF3/He chemistry) – Fig. 7d. The
Si3N4 layer, from the backside of the wafer, was
also removed using a similar RIE process. On the
back of the wafer, an aluminum layer was
sputtered in order to achieve a good electric
contact for next electrochemical process (Fig. 7e).
Then the porous silicon was generated only on
the tip of the microneedle using a classical
anodization process, while as the needle body
was protected by the remaining Si3N4 layer (Fig.
7f). Fig. 8 shows the experimental setup of the
anodic electrochemical etching process [33]. The
Pt electrode was used as the cathode and silicon
wafer as anode. A DC power of 36~72 V was
used as the source. The used electrolyte was a
mixture of acetonitrile (MeCN) and diluted
hydrofluoric acid (HF). The mixture has two
compounds of MeCN : HF(4M) : H2O = 92% :
4% : 4% by weight. The electrochemical
anodization process was carried out at a current
intensity of 10 mA·cm-2 for 30 min. Fig. 9 shows
a SEM picture of the porous silicon tip after the
anodization process.

Fig. 7. Fabrication process flow for the porous tips: (a)
LPCVD Si3N4 deposition, (b) photoresist coating, (c)
photoresist reflowing and O2 plasma, (d) Si3N4 etching in
RIE and photoresist removal, (e) Al deposition (back of the
wafer), (f) anodization.

After cleaning, a 500 nm Si3N4 layer was
deposited on the microneedles surface in PECVD

Fig. 8. Schematic view of the electrochemical anodization
process.
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receiver compartments were then clamped
together. The receiver compartment was filled
with phosphate buffered saline (PBS) solution
while the temperature of water bath was
maintained at 37°C. Figure 10 illustrates the
experimental setup. For a better comparison, the
drug release experiments were carried out in four
parallel sessions: using passive diffusion through
the skin, using the microneedles array.

Fig. 9. SEM picture of the porous silicon tip.

4. DRUG DELIVERY USING
MICRONEEDLES ARRAY WITH
BIODEGRADABLE TIPS
4.1

Skin model

The microneedle array was applied to the in
vitro transdermal drug delivery model using pig
skin. Pig skins were used in the experiment due
to their similar physiological properties with the
human skin. All animal procedures were
performed in compliance with relevant
regulations approved by the Institutional Animal
Care and Use Committee of National University
of Singapore. For the pig skins preparation, the
skin were excised from the pig immediately after
the pigs were sacrificed. The excised skins were
fixed on top of plastic foam with the epidermis
layer facing up. The adhering fat and other
visceral debris in the skin were then carefully
removed. The underlying subcutaneous fat was
gently scraped off until the skin was about 1 mm
thick. The prepared skins were washed, wrapped
in aluminum foil, and stored at –80ºC.
4.2 In vitro delivery testing setup
A Franz diffusion cell (Logan Instruments
Corp., Somerset, NJ) was used for the in vitro
drug release. The pig skin was removed from the
refrigeration chamber 1 hour before each
experiment and mounted onto a Franz diffusion
cell, with the stratum corneum side facing to the
donor compartment. The microneedle array was
then pressed onto the surface of the skin, and
held by the donor compartment. The donor and

Fig. 10. Illustration of the in vitro transdermal delivery with
the microneedles enhancer.

4.3 Materials for testing
The drugs tested in the experiments were
calcein (at a concentration of 10-3 mol/l, or 623
Da) and bovine serum albumin (BSA, molecular
weight 66430 Da) with the concentration of 10-3
mol/l. The permeability and transport of calcein
across the skin was detected using UV-visible
spectrophotometry (Agilent 8453 UV– vis
system). The excitation wavelength of calcein
was set to 480 nm. The same method was
employed for BSA detection, but excitation
wavelength in this case was 280 nm.
4.4 Experimental results of calcein
and BSA delivery
Microneedles were inserted into the pig skin to
generate conduits or microchannels for the
transport of drugs across the stratum corneum.
Once the delivery compound crosses the stratum
corneum, it diffuses rapidly through the deeper
tissue and is taken up by the underlying
capillaries for systemic administration. The drug
release profiles from the two kinds of transdermal
delivery were compared and the results are shown
in Fig. 11. The skin permeability of calcein was
greatly enhanced to 5-6 times with microneedles,
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compared to the passive transdermal delivery
without microneedles. In other words, the total
drug release with passive diffusion in 24 hours
can be delivered in 7 hours with microneedles.
Similarly, the drug release profiles from the two
kinds of transdermal delivery were compared and
the results are shown in Fig. 12. The skin
permeability of BSA with microneedls was
enhanced by ~7 times compared to the bare skin
diffusion. This enhancement was attributed to the
microchannels and pathways in the skin tissue
created by the microneedles, which greatly
increased the permeability of the skin.
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